BrainStorm Cell Therapeutics
BCLI
#10933
Rank
C$15 M
Marketcap
C$1.36
Share price
1.16%
Change (1 day)
48.97%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -C$14.7 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$14.6 Million, an increase over its 2024 earnings that were of -C$16.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$14.7 Million0.68%
2025 -C$14.6 Million-11.32%
2024 -C$16.47 Million-32.39%
2023 -C$24.36 Million-29.18%
2022 -C$34.39 Million-0.74%
2021 -C$34.65 Million-23.12%
2020 -C$45.07 Million36.8%
2019 -C$32.94 Million66.71%
2018 -C$19.76 Million181.66%
2017 -C$7.02 Million-0.6%
2016 -C$7.06 Million-41.31%
2015 -C$12.03 Million-8.22%
2014 -C$13.1 Million89.74%
2013 -C$6.91 Million42.27%
2012 -C$4.86 Million-12.45%
2011 -C$5.55 Million63.04%
2010 -C$3.4 Million35.52%
2009 -C$2.51 Million-48.99%
2008 -C$4.92 Million-44.39%
2007 -C$8.85 Million
2005 -C$4.58 Million-91.44%
2004 -C$53.52 Million94007.62%
2003 -C$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
C$1.43 B-9,712.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.77 Billion 18,480.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-C$1.12 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.27 Billion 8,396.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.21 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-C$0.37 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA